Turtle Creek Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Buy
60,278
+37,765
+168% +$8.8M 0.81% 34
2026
Q1
$5.5M Buy
22,513
+2,578
+13% +$600K 0.42% 63
2025
Q4
$4.13M Buy
19,935
+1,908
+11% +$377K 0.32% 75
2025
Q3
$3.34M Buy
18,027
+10,013
+125% +$1.72M 0.3% 79
2025
Q2
$1.22M Buy
+8,014
New +$1.23M 0.14% 107
2024
Q4
Sell
-5,588
Closed -$906K 121
2024
Q3
$906K Buy
5,588
+372
+7% +$59.3K 0.18% 77
2024
Q2
$762K Buy
5,216
+1,076
+26% +$160K 0.18% 74
2024
Q1
$655K Buy
4,140
+1,394
+51% +$222K 0.16% 82
2023
Q4
$430K Buy
+2,746
New +$421K 0.13% 97

Other funds holding JNJ

Turtle Creek Wealth Advisors's JNJ Position: Q2 2026 in Review

Turtle Creek Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 168% in Q2 2026, buying an estimated $8.8M and bringing the position to 60,278 shares worth $15.3M. The position accounts for 0.81% of the portfolio, ranked #34.

Turtle Creek Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 9 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Turtle Creek Wealth Advisors held 60,278 shares of Johnson & Johnson worth $15.3M as of Q2 2026.
  • Turtle Creek Wealth Advisors bought 37,765 Johnson & Johnson shares in Q2 2026, an estimated $8.8M.
  • Johnson & Johnson made up 0.81% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #34 holding.
  • Turtle Creek Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 9 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.